Abstract
Pseudomyxoma peritonei (PMP) is a nonmetastasizing locally persistent cancer that arises from a mucinous epithelial tumor of the gastrointestinal tract, usually the appendix or colon. The clinical syndrome is characterized by a primary tumor of low malignant potential that causes extensive spread of mucinous tumor deposits throughout the abdomen and pelvis. It has a characteristic clinical syndrome and histopathology that have recently been described by Sugarbaker et al. and by Zahn et al. [1,2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In Sugarbaker PH, ed Peritoneal Carcinomatosis: Diagnosis and Treatment. Norwell, MA: Kluwer Academic, 1995, pp xxx–xxx.
Zahn C, Kurman RJ, Shmookler BM, Jablonski KA, Sugarbaker PH, Kass M, Banez-Sese G, Ronnett B. Pseudomyxoma peritonei: A proposed grading system (abstract). United States and Canadian Academy of Pathology, 1993.
Sugarbaker PH. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathobiology. In Sugarbaker PH, ed Peritoneal Carcinomatosis: Principles of Management. Norwell, MA: Kluwer Academic, 1995, pp 79–100.
Sugarbaker PH. Pseudomyxoma peritonei: A cancer whose biology is characterized by a redistribution phenomena (editorial). Ann Surg 1994;219:109–111.
Sugarbaker PH. Surgical treatment of peritoneal carcinomatosis. Can J Surg 1989;32:164–170.
Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, Naessens M, O’Brien PC, van Heerden JA. Pseudomyxoma peritonei: Long term patient survival with an aggressive regional approach. Ann Surg 1994;219:xxx–xxx.
Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma peritonei of appendiceal origin. Cancer 1992;70:396–401.
Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221:29–42.
Sugarbaker PH, Graves T, deBrujin EA, Cunliffe WJ, Mullins RE, Hull WE, Oliff L, Schlag P. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 1990;50:5790–5794.
Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124–132.
Sugarbaker PH, Gunderson LL, Wittes RE. Colorectal cancer. In DeVita VT, Hellman S, Rosenberg SA, eds Cancer: Principles and Practice of Oncology, Vol. 1, 2nd ed Philadelphia: JB Lippincott, 1985, pp 795–884.
Sugarbaker PH, Ryan AM. Treatment of Peritoneal Carcinomatosis: A Manual for Physicians and Nurses. Grand Rapids, MI: Ludann, 1993.
Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993;72:1631–1636.
Fisher RA. Statistical Methods for Research Workers, 5th ed Edinburg: Oliver and Boyd, 1934.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 1956;22:719–748.
Fleiss J. Statistical Methods for Rates and Proportions, 2nd ed New York: John Wiley & Sons, 1981.
Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Meyers CE. Prospective randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985;98:414–421.
van Oosterom AT, Jol C, de Bruijn EA, Pauwels EKJ, Kuin C, Trimbos JB, Nooy MA, Tjaden UR. Intraperitoneal chemotherapy with mitomycin C in patients with resistant ovarian cancer. In Taguchi T, Andrysek O, eds New Trends in Cancer Chemotherapy with Mitomycin C. Tokyo: Excerpta Medica, 1987, pp 192–200.
Fujimoto S, Takahashi M, Endoh F, Shrestha RD, Kokubun M, Takai M, Okui K. A clinical pilot study combining surgery with intraoperative pelvic hyperthermochemotherapy to prevent the local recurrence of rectal cancer. Ann Surg 1991;213:43–47.
Fernández-Trigo V, Stuart OA, Stephens AD, Hoover LD, Sugarbaker PH. Surgically directed chemotherapy: Heated abdominal lavage with mitomycin C. In Sugarbaker PH, ed Peritoneal Carcinomatosis: Drugs and Diseases. Norwell, MA: Kluwer Academic, 1995, pp 51–61.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Sugarbaker, P.H., Fernández-Trigo, V., Shamsa, F. (1996). Clinical determinants of treatment failure in patients with pseudomyxoma peritonei. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Drugs and Diseases. Cancer Treatment and Research, vol 81. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1245-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1245-1_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-3726-3
Online ISBN: 978-1-4613-1245-1
eBook Packages: Springer Book Archive